DULAC EDWARD J III (EVP, Chief Financial Officer) sold 2.9% of their position (4.68K shares) of INTELLIA THERAPEUTICS, INC. on the open market
Open‑market sale worth $84.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/6/2026ACC: 0001821530-26-000002
Officer· EVP, Chief Financial Officer
Since Mar 2026
-4.68K
Net shares
Net seller
$84.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4.68K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.68K
Price / share
$18.00
Trade value
$84.19K
% of position
2.9%
7/2/2026
160.96K→156.29K
Total
Net shares
−4.68K
Net value
-$84.19K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/2/2026 | S · Sale | −4.68K | $18.00 | $84.19K | 2.9% | 160.96K | 156.29K |
| Total | −4.68K | -$84.19K | ||||||
Derivative Transactions0
No derivative transactions reported